Search research articles
Contact Us
Filters
Showing results (1-10 of 217) with videos related to
Page
of 22
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2018
2018 SNMMI Highlights Lecture: Brain Nuclear and Molecular Imaging
Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 2, 2020
First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease
Henryk Barthel
The Lancet. Oncology
|
September 10, 2002
Endostatin imaging to help understanding of antiangiogenic drugs
Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 9, 2020
Switching on Brain PET to Light Up Amyloid Pathology In Vivo
Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2019
2019 SNMMI Highlights Lecture: Neurosciences
Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 23, 2023
Amyloid Imaging-Based Food and Drug Administration Approval of Lecanemab to Treat Alzheimer Disease-What Lasts Long Finally Becomes Good?
Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 4, 2020
A Conversation Between David Collingridge and Henryk Barthel
David Collingridge, Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 19, 2017
Clinical Use and Utility of Amyloid Imaging
Henryk Barthel, Osama Sabri
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 6, 2025
Imaging and Fluid Biomarkers of Alzheimer Disease: Complementation Rather Than Competition
Alexander Drzezga, Henryk Barthel
Journal of Alzheimer'S Disease : JAD
|
October 6, 2011
Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET
Henryk Barthel, Osama Sabri
Page
of 22
Search research articles
Search
Showing results (1-10 of 217) with videos related to
Sort By:
Page
of 22
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2018
2018 SNMMI Highlights Lecture: Brain Nuclear and Molecular Imaging
Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 2, 2020
First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease
Henryk Barthel
The Lancet. Oncology
|
September 10, 2002
Endostatin imaging to help understanding of antiangiogenic drugs
Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 9, 2020
Switching on Brain PET to Light Up Amyloid Pathology In Vivo
Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2019
2019 SNMMI Highlights Lecture: Neurosciences
Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 23, 2023
Amyloid Imaging-Based Food and Drug Administration Approval of Lecanemab to Treat Alzheimer Disease-What Lasts Long Finally Becomes Good?
Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 4, 2020
A Conversation Between David Collingridge and Henryk Barthel
David Collingridge, Henryk Barthel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 19, 2017
Clinical Use and Utility of Amyloid Imaging
Henryk Barthel, Osama Sabri
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 6, 2025
Imaging and Fluid Biomarkers of Alzheimer Disease: Complementation Rather Than Competition
Alexander Drzezga, Henryk Barthel
Journal of Alzheimer'S Disease : JAD
|
October 6, 2011
Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET
Henryk Barthel, Osama Sabri
Page
of 22